Dose Ranging Study to Evaluate the Efficacy and Safety of MEDI8852 in Adults Who Are Hospitalized With Type A Influenza.

NCT03028909 · clinicaltrials.gov ↗

PHASE2

Phase

WITHDRAWN

Status

INDUSTRY

Sponsor class

Stopped Study is withdrawn due to company decision.

Conditions

Influenza - Type A Strains

Interventions

DRUG: Oseltamivir
DRUG: MEDI8852
DRUG: Placebo

Sponsor

MedImmune LLC